Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor β2 upregulation

AIDS Research and Human Retroviruses

Volumn 19, Issue 4, 2003, Pages 283-292

  Jones, Matthew L ^a   Young, Judy M ^a   Huang, Qi Rong ^a   Puls, Rebekah L ^a   Webber, Carolyn A ^a   Benson, Elizabeth M ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN RECEPTOR BETA 1; MESSENGER RNA; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL SURFACE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA ANALYSIS; SEROTYPE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS IMMUNITY; VIRUS TRANSCRIPTION;

HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RECOMBINANT PROTEINS; RNA, MESSENGER; UP-REGULATION;

EID: 0037391449     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203764969483     Document Type: Article

References (58)

1. Stephenson J: International ADS conference faces new realism of advances, obstacles. JAMA 1998;280:587-590.
2. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, and Lewis MG: Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000;6:207-210.
3. Kaul R, Trabattoni D, Bwajo JJ, Arienti D, Zagliani A, Mwangi FM, Kariuki C, Ngugi EN, MacDonald KS, Ball TB, Clerici M, and Plummer FA: HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;13:23-29.
4. + lymphocytes. Science 1999;283:857-860.
5. + T cell depletion in simian immunodeficiency virus infected macaques. J Exp Med 1999;189:991-998.
6. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, Blanchard T, Ariyoshi K, Oyugi J, Ngugi E, Bwayo J, MacDonald KS, McMichael AJ, and Plummer FA: Cytotoxic T cell response to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998;102:1758-1765.
7. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, and McMichael AJ: Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-2106.
8. Wasik TJ, Wierzbicki A, Whiteman VE, Trinchieri G, Lischner HW, and Kozbor D: Association between HIV-specific T helper responses and CTL activities in pediatric AIDS. Eur J Immunol 2000;30:117-127.
9. Bonavida B, Katz J, and Gottlieb M: Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Immunol 1986;137:1157.
10. Koup RA, Safrit JT, Cao Y, Andrew CA, McLeod G, Borkowsky W, Farthing C, and Ho DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68: 4650-4655.
11. Lieberman J, Shankar P, Manjunath N, and Andersson J: Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001;98:1667-1677.
12. Murray HW, Rubin BY, Masur H, and Roberts RB: Impaired production of lymphokines and immune (γ) interferon in the acquired immunodeficiency syndrome. New Engl J Med 1984;310:883.
13. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84: 4008-4027.
14. Trinchieri G: Interleukin-12: A cytokine at the interface of inflammation and immunity. Adv Immunol 1998;70:83-243.
15. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, and Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997;185: 825-831.
16. Desai BB, Quinn PM, Wolitzky AG, Mongini PKA, Chizzonite R, and Gately MK: IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol 1992;148:3125-3132.
17. Nagayama H, Sato K, Kawasaki H, Enomoto M, Morimoto C, Tadokoro K, Juji T, Asano S, and Takahashi TA: IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J Immunol 2000;165:59-66.
18. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, and Gubler U: A functional interleukin 12 receptor complex is composed of two β-type subunits. Proc Natl Acad Sci USA 1996;93:14002-14007.
19. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, and Presky DH: The interleukin-12/interleukin-12 receptor system: Role in normal and pathologic immune responses. Annu Rev Immunol 1998;16:495-521.
20. Zou J, Presky DH, Wu CY, and Gubler U: Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits β1 and β2 and JAK kinases. J Biol Chem 1997;272: 6073-6077.
21. Bacon CM, McVicar DW, Ortaldo JR, Rees RC, O'Shea JJ, and Johnston JA: Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: Differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med 1995;181:399-404.
22. Bacon CM, Petricoin CF, Ortaldo JR, Rees QC, Larner AC, Johnston JA, and O'Shea JJ: Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 1995;92:7307-7311.
23. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, and Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994;179:1361-1366.
24. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, and Griffin DE: Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996;273:228-231.
25. Vecchiarelli A, Monari C, Palazzetti B, Bistoni F, and Casadevall A: Dysregulafion in IL-12 secretion by neutrophils from HIV-infected patients. Clin Exp Immunol 2000;121:311-319.
26. Chougnet C, Kovacs A, Baker R, Mueller BU, Luban NLC, Liewehr DJ, Steinberg SM, Thomas EK, and Shearer GM: Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis 2000;181:1590-1597.
27. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, and Shearer GM: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993;262:1721-1724.
28. + T cell proliferation and production of IFN-γ in response to p24 antigen in HIV-infected individuals: Potential contribution of anergy to HIV-specific unresponsiveness. J Immunol 2000;165:1685-1691.
29. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayashi M, Perussia B, Young D, Nickbarg E, Wolf SF, and Trinchieri G: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 1992;175:789-796.
30. Young JM, Ffrench RA, Clarkson JD, Stewart GJ, Liang T, Tideman RL, Packham D, Fulcher DA, and Benson EM: In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12). AIDS Res Hum Retroviruses 2001;17:233-242.
31. Jacobson MA, Hardy D, Connick E, Watson J, and DeBruin M: Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/μL. J Infect Dis 2000;182:1070-1076.
32. Wu CY, Warrior RR, Wang X, Presky DH, and Gately MK: Regulation of interleukin-12 receptor β1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Eur J Immunol 1997;27;147-154.
33. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260: 547-549.
34. Manetti R, Parronchi P, Giudizi MG, Piccinni M-P, Maggi E, Trinchieri G, and Romagnani S: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of 1L-4 producing Th cells. J Exp Med 1993;177:1199-1204.
35. Orange JS, Wolf SF, and Biron CA: Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994;152:1253-1264.
36. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, and Gately MK: IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity 1996;4:471-481.
37. Nagy-Agren SE and Cooney EL: Interleukin-12 enhancement of antigen-specific lymphocyte proliferation correlates with stage of human immunodeficiency virus infection. J Infect Dis 1999;179: 493-496.
38. Landay AL, Clerici M, Hashemi F, Kessler H, Berzofsky JA, and Shearer GM: In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: Effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis 1996;173:1085-1091.
39. Uherova P, Connick E, MaWhinney S, Schlichtemeier R, Schooley RT, and Kuritzkes DR: In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1. J Infect Dis 1996;174:483-489.
40. Newman GW, Guarnaccia JR, Vance EA, Wu JY, Remold HG, and Kazanjian PH: Interleukin-12 enhances antigen-specific proliferation of peripheral blood mononuclear cells from HIV-positive and negative donors in response to Mycobacteriurn avium. AIDS 1994;8:1413-1419.
41. Seder RA, Grabstein KH, Berzofsky JA, and McDyer JF: Cytokine interactions in human immunodeficiency virus-infected individuals: Roles of interleukin (IL)-2, IL-12, and IL-15. J Exp Med 1995; 182:1067-1078.
42. + CTL responses in vitro. J Clin Invest 1996;98:715-722.
43. Vanham G, Penne L, Fransen K, Kestens L, and De Brabander M: HIV-associated dysfunction of in vitro IL-12 production depends on the nature of the stimulus and on the CD4 T-cell count of the patient. Blood 2000;95:2185-2187.
44. Torre D, Zeroli C, Ferrario G, Bonetta G, Giola M, Speranza F, and Fiori GP: Serum levels of interleukin-12 in adult and paediatric patients with HIV-1 infection. AIDS 1995;9:405-406.
45. Anderson J, Fehniger TE, Patterson BK, Pottage J, Agnoli M, Jones P, Behbahani H, and Landay A: Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 1998;12:123-129.
46. Wu CY, Wang X, Gadina M, O'Shea JJ, Presky DH, and Magram J:IL-12 receptor β2 (IL-12Rβ2)-deficient mice are defective in IL-12-mediated signalling despite the presence of high affinity IL-12 binding sites. J Immunol 2000;165:6221-6228.
47. Vingerhoets J, Bisalinkumi E, Penne G, Colebunders R, Bosmans E, Kestens L, and Vanham G: Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett 1998;61:53-61.
48. Rogge L, Papi A, Presky DH, Biffi M, Minetti LJ, Miotto D, Agostini C, Semenzato G, Fabbri LM, and Sinigaglia F: Antibodies to the IL-12 receptor β2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol 1999;162:3926-3932.
49. Galbiati F, Rogge L, Guery JC, Smiroldo S, and Adorini L: Regulation of the IL-12 receptor β2 subunit by soluble antigen and IL-12 in vivo. Eur J Immunol 1998;28:209-220.
50. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, and Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100:655-669.
51. Mullen AC, High FA, Hutchines AS, Lee HW, Villarino AV, Livingston DM, Kung AL, Cereb N, Yao T-P, Yang SY, and Reiner SL: Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 2001;292:1907-1910.
52. Marshall JD, Chehimi J, Gri G, Kostman JR, Montaner LJ, and Trinchieri G: The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 1999;94:1003-1011.
53. Pietrella D, Kozel TR, Monari C, Bistoni F, and Vecchiarelli A: Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans. J Infect Dis 2001; 183:51-58.
54. Ito M, Ishida T, He L, Tanabe F, Rongge Y, Miyakawa Y, and Terunuma H: HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1998;14:845-849.
55. Showe LC, Fox FE, Williams D, Au K, Niu Z, and Rook AH: Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor β2 mRNA and highly reduced levels of STAT4. J Immunol 1999;163:4073-4079.
56. van Rietschoten JGI, Smits HH, van de Wetering D, Westland R, Verweij CL, den Hartog MT, and Wierenga EA: Silencer activity of NFATc2 in the interleukin-12 receptor β2 proximal promoter in human T helper cells. J Biol Chem 2001;276:34509-34516.
57. Wang KS, Zorn E, and Ritz J: Specific down-regulation on interleukin-12 signaling through induction of phospho-STAT4 protein degradation. Blood 2001;97:3860-3866.
58. Wu C-Y, Gadina M, Wang K, O'Shea, and Seder R: Cytokine regulation of IL-12 receptor β2 expression: Differential effects on human T and NK cells. Eur J Immunol 2000;30:1364-1374.